Developments in the clinical science of transplantation during the 20th century

Pediatric Transplantation

Volumn 2, Issue 4, 1998, Pages 257-262

  Vella, John P ^a   Sayegh, Mohamed H ^a   Turka, Laurence A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Immunobiology; Immunosuppression; Tolerance; Transplantation

Indexed keywords

CHILD; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; METHODOLOGY; PEDIATRICS; REVIEW; STATISTICS; TRANSPLANTATION;

CHILD; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; INFECTION CONTROL; PEDIATRICS; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 0032196234     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. KUSS R, BOURGET P. An illustrated history of organ transplantation. Rueil-Malmaison: Sandoz, 1992.
2. HUME DM, MERRILL JP, MILLER BF, THORN GW. Experiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest 1955: 34: 327-382.
3. RICHET G. Hamburger's achievement with early renal transplants. Am J Nephrol 1997: 17: 315-317.
4. MERRILL JP, MURRAY JE, HARRISON JH, et al. Successful homotransplantation of a kidney in identical twins. Trans Amer Clin Climatol 1955: 67: 167.
5. SCHWARTZ R, DEMASHEK W. Drug induced immunological tolerance. Nature 1959: 183: 1682-1685.
6. KAHAN BD. Drug Therapy: Cyclosporine. N Engl J Med 1989: 321: 1725-1738.
7. CARPENTER CB. Long term failure of renal transplants: adding insult to injury. Kidney Int 1995: 48: S40.
8. VELLA JP, SAYEGH MH. Maintenance pharmacological immunosuppressive strategies in renal transplantation. Postgrad Med J 1997: 73: 386-390.
9. BIERER B. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opinion Immunol 1993: 5(5): 763-773.
10. MORRIS RE. Rapamycins: antifungal, antiproliferative and immunosuppressive macrolides. Transplant Rev 1992: 6: 39-45.
11. VELLA JP, SAYEGH MH. Current and future immunosuppressive therapies: impact on chronic allograft dysfunction. J Nephrol 1997: 10: 229-231.
12. HALLORAN P, MATHEW T, TOMLANOVICH S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997: 63: 39-47.
13. SOULILLOU JP, PEYRONNET P, LE MB, et al. Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. Lancet 1987: 1: 1339-1342.
14. VINCENTI F, KIRKMAN R, LIGHT S, BUMGARDNER G. et al. Interleukin-2-Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation. N Engl J Med 1998: 338: 161-165.
15. GJERTSON D, CECKA J, TERASAKI P. The relative effects of FK506 and cyclosporine on short- and long-term graft survival. Transplantation 1995: 60: 1384-1388.
16. TULLIUS SG, TILNEY NL. Both alloantigen-dependent and - independent factors influence chronic allograft rejection. Transplantation 1995: 59: 313-318.
17. CHO YW, TERASAKI PI, CECKA JM, GJERTSON DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998: 338: 221-225.
18. SAYEGH MH, TURKA LA. The role of T cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998: 338: 1813-1821.
19. BJORKMAN PJ, DAVIS MM. Model for the interaction of T-cell receptors with peptide/MHC complexes. Cold Spring Harbor Symp. Quant. Biol. 1989: 54: 365-373.
20. HALLORAN PF, HOMIK J, GOES N, et al. The "injury response": a concept linking nonspecific injury, acute rejection, long-term transplant outcomes. Transplant Proc 1997: 29: 79-81
21. TAKADA M, CHANDRAKER A, NADEAU KC, SAYEGH MH, TILNEY NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997: 100: 1199-1203.
22. VELLA JP, SPADAFORA FM, MURPHY B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997: 64: 795-800.
23. CIUBOTARIU R, LIU Z, COLOVAI AI, et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998: 101: 398-405.
24. BLUESTONE JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995: 2: 555-559.
25. THOMPSON CB. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995: 81: 979-982.
26. WALUNAS TL, LENSCHOW DJ, BAKKER CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994: 1: 405-413.
27. BILLINGHAM RE, BRENT L, MEDAWAR P. Actively acquired tolerance of foreign cells. Nature 1953: 172: 603-606.
28. CHANDRAKER A, RUSSELL ME, GLYSING JT, WILLETT TA, SAYEGH MH. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. Transplantation 1997: 63: 1053-1058.
29. SYKES M, SACHS DH. Bone marrow transplantation as a means of inducing tolerance. Semin Immunol 1990: 2: 401-417.
30. NAJI A. Induction of tolerance by intrathymic inoculation of alloantigen. Curr Opin Immunol 1996: 8: 704-709.
31. CHEN W, SAYEGH MH, KHOURY SJ. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy [In Process Citation]. J Immunol 1998: 160: 1504-1508.
32. VELLA JP, KNOFLACH A, WAAGA A, SAYEGH MH. T cell mediated immune responses in chronic allograft rejection: Role of indirect allorecognition and costimulation. Graft 1998: 1: 13-20.
33. LARSEN CP, ELWOOD ET, ALEXANDER DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996: 381: 434-438.
34. STARZL T, DEMETRIS A, MURASE N, et al. Donor cell microchimerism permitted by immunosuppressive drugs; a new view of organ transplantation. Immunol Today 1993: 14: 326-332.
35. THOMAS JM, VERBANAC KM, SMITH JP, et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995: 59: 245-55.
36. GARCIA-MORALES R, CARRENO M, MATHEW J, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow analyses in kidney transplant recipients. J Clin Invest 1997: 99: 1118-1129.
37. CECKA JM, GJERTSON DW, TERASAKI PI. Pediatric renal transplantation: A review of the UNOS data. Pediatric Transplantation 1997: 1: 55-64.
38. SCORNIK JC, PFAFF WW, HOWARD RJ, et al. Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation 1994: 58: 1361-1365.
39. VELLA JP, O'NEILL D, ATKINS N, DONOHOE JF, WALSHE JJ. Sensitisation to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplantation 1998 (in press).
40. BENFIELD MR, VAIL A, WALDO FB, BUCY RP, KOHAUT EC. The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation. Pediatric Transplantation 1997: 1: 90-97.
41. STREHLAU J, PAVLAKIS M, LIPMAN M, et al. The intragraft gene activation of markers reflecting T-cell-activation and - cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996: 46: 30-33.